Essential resource for members containing prescribing information on drugs currently available to treat eye conditions.
Information on the diagnosis and treatment of 60 various eye conditions that present in practice.
Additional guidance and useful links for members with an independent prescribing qualification.
The Royal College of Ophthalmologists works with the UK Ophthalmic Pharmacy Group to provide a list of drug shortages on their website.
Members with an independent prescribing qualification can create private prescriptions in their My College area.
Advice in our Guidance for Professional Practice.
We often run dedicated therapeutics online peer reviews, which are open to IP qualified members. Check our events listings for the latest peer reviews.
If you are a College member studying for your IP qualification, access your online logbook in your My College area.
Improve your skills and knowledge in diagnosis and patient management on this updated online CPD course for independent prescribing optometrists.
Clinical files: Can I prescribe medicines for intravitreal injection for the management of wet AMD patients?
Optometrists have evolved from prescribers of spectacles to crucial primary care providers, writes Becky McCall.
An online dedicated therapeutics peer review session for College members who are qualified independent prescribers.
Optometrists with an independent prescribing (IP) qualification are able to clinically assess a patient, establish a diagnosis, determine the clinical management required and prescribe where necessary.
The consultation seeks views on extending the range of medicines available to optometrists and contact lens opticians.
As part of its 10-Year Health Plan, the government is proposing to extend the range of prescription-only medicines available for optometrists to supply under the medicines exemptions legislation.
In this updated online CPD course for optometrists you will be given the background to four patients and will complete a series of activities related to each case.
Adrian O’Dowd considers what optometrists should bear in mind when prescribing treatments that may have serious side effects.